S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:TTNP

Titan Pharmaceuticals (TTNP) Stock Price, News & Analysis

$7.16
-0.22 (-2.98%)
(As of 03/28/2024 ET)
Today's Range
$6.85
$7.32
50-Day Range
$5.33
$9.41
52-Week Range
$5.00
$16.90
Volume
10,222 shs
Average Volume
12,608 shs
Market Capitalization
$5.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TTNP stock logo

About Titan Pharmaceuticals Stock (NASDAQ:TTNP)

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

TTNP Stock Price History

TTNP Stock News Headlines

Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Titan Pharmaceuticals Inc (TTNP)
Titan Pharmaceuticals, Inc. (TN70.F)
Titan Pharmaceuticals Inc TTNP
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
TTNP - Titan Pharmaceuticals, Inc.
TTNP Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals Provides Shareholder Update
See More Headlines
Receive TTNP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Titan Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/30/2021
Today
3/29/2024
Next Earnings (Estimated)
4/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TTNP
Employees
4
Year Founded
1992

Profitability

Net Income
$-10,210,000.00
Net Margins
-2,021.31%
Pretax Margin
-2,021.31%

Debt

Sales & Book Value

Annual Sales
$560,000.00
Book Value
$1.86 per share

Miscellaneous

Free Float
565,000
Market Cap
$5.37 million
Optionable
Optionable
Beta
1.34

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. David Elliot Lazar (Age 33)
    CEO & Principal Financial Officer
    Comp: $726.08k
  • Dr. Katherine L. Beebe-DeVarney Ph.D. (Age 63)
    President, COO & Director
    Comp: $308k
  • Mr. Mike Fritz
    National Sales Director
  • Jennifer Kiernan
    Executive Assistant to CEO & Investor Communications Coordinator
  • Joe Schrei
    Executive Director of Commercial Operations

TTNP Stock Analysis - Frequently Asked Questions

How have TTNP shares performed in 2024?

Titan Pharmaceuticals' stock was trading at $8.25 on January 1st, 2024. Since then, TTNP stock has decreased by 13.2% and is now trading at $7.16.
View the best growth stocks for 2024 here
.

When is Titan Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 2nd 2024.
View our TTNP earnings forecast
.

How were Titan Pharmaceuticals' earnings last quarter?

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) posted its quarterly earnings data on Tuesday, March, 30th. The specialty pharmaceutical company reported ($17.20) earnings per share for the quarter, topping the consensus estimate of ($26.60) by $9.40. Titan Pharmaceuticals had a negative net margin of 2,021.31% and a negative trailing twelve-month return on equity of 302.61%.

When did Titan Pharmaceuticals' stock split?

Shares of Titan Pharmaceuticals reverse split before market open on Tuesday, January 9th 2024. The 1-20 reverse split was announced on Tuesday, January 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Titan Pharmaceuticals own?
Who are Titan Pharmaceuticals' major shareholders?

Titan Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Titan Pharmaceuticals?

Shares of TTNP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TTNP) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners